ArticleFrontiers in oncology2026

Sequential almonertinib therapy following osimertinib-induced interstitial lung disease in early-stage EGFR-mutant lung adenocarcinoma: a case report.

Jianbin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.